Calcilytix Therapeutics Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Calcilytix Therapeutics's estimated annual revenue is currently $2.3M per year.(i)
  • Calcilytix Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Calcilytix Therapeutics has 15 Employees.(i)
  • Calcilytix Therapeutics grew their employee count by 150% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on developing a targeted therapy for disorders of calcium homeostasis. Our product candidate, encaleret, is an investigational orally-administered small molecule designed to specifically inhibit the calcium-sensing receptor, hypothesized to restore normal serum calcium and lower urine calcium.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

150%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M150%$100M
#2
$1.4M15-17%N/A
#3
$1.3M150%N/A
#4
$0.5M15-6%$34M
#5
$0.4M15-42%$156.1M